VANTAGE (Vanderbilt Technologies for Advanced Genomics) is a genomics core laboratory consolidation initiated by an $8.6 million ARRA funded NIH grant award to Vanderbilt University Medical Center, with an overall goal of creating a new collaborative shared resource that accelerates discovery in genome sciences and personalized medicine, providing state-of-the art research shared resource facilities and technology.

The NIH grant provided funds for complete modernization of 12,505 Net Square Feet of aging laboratory space in Medical Center North, and for new cutting edge scientific equipment now utilized by the core labs located in the newly renovated space. Renovation was completed in May 2012, and the core labs (see below) are now in full service mode in their new laboratories.

The next phase of consolidation is now underway, with the operational merger of the DNA Resources and Genome Sciences Resource cores. All of the services currently offered by these cores will continue, including: Illumina genotyping, DNA extraction and banking, Sanger sequencing and Next Generation Sequencing (NGS) among many other specialized services. In the reorganization, these activities will now become part of an overall structure that takes full advantage of their new physical co-location together with the Flow Cytometry Shared Resource in VANTAGE.

VANTAGE works closely with VANGARD (VANderbilt Technologies for Advanced Genomics Analysis and Research Design). These cores have been established to work together to assist researchers in experimental design and results evaluation.